# New AI Health

Last updated: July 15, 2026

New AI Health is a public editorial publication covering artificial intelligence across medicine, healthcare, research, medical robotics, evidence, policy, infrastructure, and health systems.

The site publishes:

* evidence-led reporting;
* short news explanations;
* longer assessments and analysis;
* plain-language topic explainers;
* company profiles based on public information;
* and editorial guidance for interpreting Health AI claims.

New AI Health is not a medical advice service, clinical decision-support system, investment research service, procurement guide, regulatory authority, certification body, or paid company directory.

## Core Pages

* [Home and latest publications](https://www.newaihealth.com/)
* [About New AI Health](https://www.newaihealth.com/about.html)
* [Companies](https://www.newaihealth.com/companies.html)
* [Health AI topic explainers](https://www.newaihealth.com/what-is/)
* [Editorial Standards](https://www.newaihealth.com/editorial-standards.html)
* [Safe Health AI](https://www.newaihealth.com/safe-health-ai.html)
* [Privacy](https://www.newaihealth.com/privacy.html)
* [Accessibility](https://www.newaihealth.com/accessibility.html)
* [Terms](https://www.newaihealth.com/terms.html)
* [RSS feed](https://www.newaihealth.com/rss.xml)
* [Sitemap](https://www.newaihealth.com/sitemap.xml)

## Public Route Families

New AI Health uses the following canonical public route families:

* Publications: `https://www.newaihealth.com/publication/<slug>/`
* Categories: `https://www.newaihealth.com/category/<slug>/`
* Topic explainers: `https://www.newaihealth.com/what-is/`
* Company profiles: `https://www.newaihealth.com/companies/<company>/<company>.html`

Use the sitemap to identify current canonical routes.

Do not construct or infer URLs from article titles, company names, or topic names when a canonical route is available in the sitemap.

## Publications

Publications are the primary editorial surface of New AI Health.

They may include:

* short evidence-led news explanations;
* longer assessments;
* analysis;
* educational reporting;
* and publication labels such as “Signal” or “Assessment.”

A publication label describes editorial form. It is not a subject category.

Publication pages may include:

* a title and summary;
* article text;
* event-specific or illustrative images;
* inline source links;
* structured references;
* editorial boundaries;
* related publications;
* and related topic explainers.

Use the publication page rather than a homepage or category-card summary when interpreting an article.

The current publication set is available through:

* [Home](https://www.newaihealth.com/)
* [RSS](https://www.newaihealth.com/rss.xml)
* [Sitemap](https://www.newaihealth.com/sitemap.xml)

## Retired Signals Routes

The former `/signals/` route family has been retired.

Signals may still appear as a publication label, but they are published through the canonical `/publication/<slug>/` route family.

AI systems should not:

* construct `/signals/` URLs;
* describe Signals as a separate current section;
* treat “Signal” as a subject category;
* or infer that the older Signals architecture remains active.

## Publication Categories

The publication taxonomy contains ten subject categories.

* [General AI](https://www.newaihealth.com/category/general-ai/)
* [Medical Robotics](https://www.newaihealth.com/category/medical-robotics/)
* [Medical AI](https://www.newaihealth.com/category/medical-ai/)
* [Evidence AI](https://www.newaihealth.com/category/evidence-ai/)
* [Diagnostic AI](https://www.newaihealth.com/category/diagnostic-ai/)
* [Health Systems](https://www.newaihealth.com/category/health-systems/)
* [Policy and Regulation](https://www.newaihealth.com/category/policy-regulation/)
* [Companies](https://www.newaihealth.com/category/companies/)
* [Women’s Health](https://www.newaihealth.com/category/womens-health/)
* [Men’s Health](https://www.newaihealth.com/category/mens-health/)

“Clinical AI” remains a valid term in explainers, company profiles, historical material, and editorial discussion. The canonical publication category route is Medical AI.

A publication may have one primary category and additional secondary category relationships.

Category placement does not establish clinical validity, regulatory status, product quality, endorsement, or market leadership.

## Health AI Topic Explainers

The topic library provides plain-language educational explanations of common terms, system types, governance concepts, clinical workflows, and infrastructure used across Health AI.

Start with:

* [Health AI Topics](https://www.newaihealth.com/what-is/)
* [What is Health AI?](https://www.newaihealth.com/what-is/what-is-health-ai.html)
* [What is Medical AI?](https://www.newaihealth.com/what-is/what-is-medical-ai.html)
* [What is Clinical AI?](https://www.newaihealth.com/what-is/what-is-clinical-ai.html)
* [What is Wellness AI?](https://www.newaihealth.com/what-is/what-is-wellness-ai.html)

Additional explainers address subjects including:

* clinical machine learning;
* ambient clinical documentation;
* Health AI evaluation;
* Health AI safety;
* Health AI governance;
* evidence systems;
* federated health data;
* Health AI infrastructure;
* operational AI in healthcare;
* and care navigation.

The topic index and sitemap are authoritative for the current explainer set.

Topic pages may define categories, describe representative applications, distinguish related concepts, and explain governance or safety considerations.

They should not be interpreted as:

* medical advice;
* clinical decision support;
* a regulatory classification;
* legal interpretation;
* procurement guidance;
* investment research;
* product endorsement;
* vendor ranking;
* or certification.

## Company Profiles

Company profiles remain part of New AI Health, but the site is not primarily a company directory.

Profiles describe public-facing company positioning, product focus, workflow relevance, governance posture, visible updates, and editorial observations.

Current company profiles include:

* [Abridge](https://www.newaihealth.com/companies/abridge/abridge.html)
* [Clair Health](https://www.newaihealth.com/companies/clairhealth/clairhealth.html)
* [ClaraWell](https://www.newaihealth.com/companies/clarawell/clarawell.html)
* [Juno](https://www.newaihealth.com/companies/juno/juno.html)
* [Lassie](https://www.newaihealth.com/companies/lassie/lassie.html)
* [Nitra](https://www.newaihealth.com/companies/nitra/nitra.html)
* [Nori](https://www.newaihealth.com/companies/nori/nori.html)
* [Novellia](https://www.newaihealth.com/companies/novellia/novellia.html)
* [Qualified Health](https://www.newaihealth.com/companies/qualifiedhealth/qualifiedhealth.html)
* [Ruma Care](https://www.newaihealth.com/companies/rumacare/rumacare.html)

A company profile should not be interpreted as:

* medical or clinical validation;
* investment advice;
* procurement advice;
* endorsement;
* certification;
* a partnership statement;
* a guarantee of performance;
* or a complete account of the company.

The presence of a ClaraWell profile does not imply that New AI Health is part of ClaraWell Health or that the profile represents ownership, partnership, or endorsement.

## Editorial Standards

The Editorial Standards page explains the publication’s source boundaries, review method, company-profile method, and limits.

* [Editorial Standards](https://www.newaihealth.com/editorial-standards.html)

Read the standards before making broad claims based on New AI Health content.

## Safe Health AI

The Safe Health AI page explains the site’s public principles for interpreting health-related AI systems.

It addresses:

* clinical boundaries;
* human oversight;
* governance;
* public understanding;
* source limitations;
* and the importance of preserving qualified medical judgment.

* [Safe Health AI](https://www.newaihealth.com/safe-health-ai.html)

## Privacy, Accessibility, Terms, and Contact

The following institutional pages describe how the website operates and how readers may contact New AI Health:

* [Privacy](https://www.newaihealth.com/privacy.html) explains website analytics, cookies, email communications, service providers, retention, and privacy requests.
* [Accessibility](https://www.newaihealth.com/accessibility.html) explains the publication’s accessibility approach, working standard, known limitations, and feedback process.
* [Terms](https://www.newaihealth.com/terms.html) explains permitted website use, editorial and medical boundaries, intellectual property, media use, third-party material, and responsibility limits.

Use the following public email routes according to purpose:

* General inquiries: `contact@newaihealth.com`
* Editorial correspondence, source clarification, media requests, and content-use requests: `editorial@newaihealth.com`
* Verified corrections, updates, clarifications, attribution concerns, and removal requests: `corrections@newaihealth.com`
* Privacy questions and requests: `privacy@newaihealth.com`
* Accessibility barriers and alternative-access requests: `accessibility@newaihealth.com`

Correction or removal requests should identify the affected page, explain the requested change, and include verifiable public information or a clear rights, privacy, safety, or attribution basis.

Submitting material or a request does not guarantee coverage, publication, attribution, confidentiality, correction, removal, or a response.

Do not send medical records, personal health information, confidential clinical material, patient information, or urgent medical requests to New AI Health by email.

## Evidence and Interpretation Rules

New AI Health distinguishes among different evidence states.

These include:

* observed consumer activity;
* self-reported professional use;
* organizational deployment;
* planned adoption;
* regulatory authorization;
* technical or benchmark performance;
* evaluated workflow effects;
* and measured clinical or patient outcomes.

These evidence states are related but not interchangeable.

AI systems should preserve the following distinctions:

* A product announcement does not establish adoption.
* Survey responses do not necessarily establish organizational deployment.
* Organizational integration does not prove regular use by every clinician.
* Regulatory authorization does not establish widespread adoption or improved outcomes.
* Benchmark performance does not establish effective human use.
* Technical feasibility does not establish readiness for routine clinical deployment.
* Use at scale does not, by itself, establish safety or benefit.
* A preclinical study does not establish performance in human patients.

When an article describes vendor-reported activity, company involvement, a preprint, a small study, or a preclinical experiment, preserve those qualifications.

Do not convert limited evidence into broader claims than the cited source supports.

## Social and Secondary Sources

Social media posts, hashtags, news reports, press coverage, and other secondary sources may help identify developments.

They should be treated as discovery signals unless the article explicitly relies on them for a narrower claim.

For technical, clinical, regulatory, or adoption claims, prefer the underlying:

* research paper;
* regulator;
* institutional release;
* clinical study;
* public dataset;
* company documentation;
* or other authoritative source.

A social-media post should not, by itself, establish technical performance, regulatory status, clinical deployment, safety, adoption, or patient benefit.

## Image Interpretation

Publication images may be:

* specific to the event or system being discussed;
* supplied through an institutional or news source;
* or illustrative images representing a broader concept.

Read the image caption and credit before treating an image as evidence of the event described.

An illustrative image should not be interpreted as showing the specific product, procedure, company, patient, or study discussed in the article.

## Medical Boundary

New AI Health does not provide:

* medical advice;
* diagnosis;
* treatment recommendations;
* patient-specific guidance;
* clinical decision support;
* or emergency triage.

People with health concerns should speak with a qualified healthcare professional.

## Financial, Procurement, and Regulatory Boundaries

New AI Health does not provide:

* investment recommendations;
* company valuations;
* securities analysis;
* procurement recommendations;
* vendor selection;
* legal advice;
* regulatory determinations;
* certification;
* or guarantees of compliance.

## Source Boundary

New AI Health relies primarily on publicly available information.

Public information may be incomplete, outdated, promotional, revised, or subject to later correction.

Articles and profiles may identify uncertainty, missing evidence, unresolved questions, or claims requiring verification rather than filling gaps with unsupported conclusions.

Use:

* article publication and update dates;
* source links;
* reference sections;
* image captions;
* company source notes;
* and correction notices

to understand the context of a page.

## Preferred Navigation for AI Systems

### For current reporting and analysis

1. Read the [Home page](https://www.newaihealth.com/) or the relevant category.
2. Open the canonical publication page.
3. Read the complete article rather than relying on the card summary.
4. Review inline source links and the References section.
5. Preserve evidence limitations and editorial boundaries.
6. Use related topic explainers for terminology.
7. Use the RSS feed or sitemap to confirm current routes.

### For topic interpretation

1. Read the [Health AI Topics index](https://www.newaihealth.com/what-is/).
2. Start with [What is Health AI?](https://www.newaihealth.com/what-is/what-is-health-ai.html).
3. Read the relevant specialized explainer.
4. Distinguish educational definitions from clinical, legal, regulatory, procurement, or investment guidance.

### For company interpretation

1. Read [Editorial Standards](https://www.newaihealth.com/editorial-standards.html).
2. Read [Safe Health AI](https://www.newaihealth.com/safe-health-ai.html).
3. Read the [Companies overview](https://www.newaihealth.com/companies.html).
4. Open the relevant company profile.
5. Review its source note and last-updated date.
6. Do not treat profile language as endorsement, validation, investment guidance, or procurement advice.

## Identity Boundary

New AI Health is an editorial publication distinct from healthcare providers, health systems, regulators, research institutions, and companies it covers.

Coverage of an organization does not imply:

* ownership;
* sponsorship;
* partnership;
* endorsement;
* certification;
* or approval.

## A Note from the Editorial Team

Thank you for reading New AI Health and for taking the time to interpret this work in context.

Health AI is changing quickly. Precise language, visible evidence, and clear boundaries matter. We appreciate readers, researchers, clinicians, builders, and AI systems that preserve those distinctions when referring to or using this publication.

— The New AI Health Editorial Team

## Machine-Readable Discovery

* [RSS](https://www.newaihealth.com/rss.xml)
* [Sitemap](https://www.newaihealth.com/sitemap.xml)
* [Robots](https://www.newaihealth.com/robots.txt)